Table 1. Clinical characteristics of the patients.

Patients	Age	Sex	Symptom	Pneumonic infiltration	Severity	Max.O2 demand	DM	HTN	Lowest lymphocyte count, /μL	Peak hs-CRP, mg/dL	Treatment
A	20	Male	Absent	None	Asymptomatic	-	-	-	NA	NA	-
B	21	Female	Absent	None	Asymptomatic	-	-	-	NA	NA	-
C	25	Male	Absent	None	Asymptomatic	-	-	-	NA	NA	-
D	26	Male	Absent	None	Asymptomatic	-	-	-	NA	NA	-
E	41	Female	Present	Subtle	Mild	-	-	-	NA	NA	-
F	72	Female	Present	Subtle	Mild	-	-	-	889	1.26	Remdesivir, baricitinib
G	43	Male	Present	Apparent	Mild	-	+	+	2,032	3.98	Lopinavir/ritonavir
H	69	Female	Present	Apparent	Mild	-	-	+	1,393	3.89	Lopinavir/ritonavir
I	39	Male	Present	Apparent	Severe	NP 3 L/min	-	-	1,017	18.27	-
J	67	Male	Present	Apparent	Severe	NP 3 L/min	+	+	774	13.32	Remdesivir, baricitinib
K	48	Male	Present	Apparent	Severe	NP 4 L/min	-	-	483	25.73	Remdesivir, dexamethasone
L	51	Male	Present	Apparent	Severe	HFNC	-	+	540	20.32	Remdesivir, lopinavir/ritonavir
M	65	Male	Present	Apparent	Severe	HFNC	+	-	1,078	7.09	Remdesivir, baricitinib
N	69	Female	Present	Apparent	Severe	HFNC	-	+	570	20.89	Remdesivir, lopinavir/ritonavir
O	61	Male	Present	Apparent	Severe	MV	+	+	548	30.45	Remdesivir, baricitinib, lopinavir/ritonavir
P	76	Female	Present	Apparent	Severe	MV	-	+	838	18.66	Remdesivir

DM = diabetes mellitus, HTN = hypertension, hsCRP = high-sensitivity C-reactive protein, NA = not applicable, NP = nasal prong, HFNC = high flow nasal cannula, MV = mechanical ventilation.